Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2J6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,271
Award facts
- Contract value 100% obligated
- $57,270.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,270.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on January 13, 2026, with completion expected by January 14, 2026. This competitively awarded, non-set-aside contract was performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime IDC serves as the vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military treatment facility requirements. The company's extensive contract portfolio with DLA demonstrates its capability to efficiently supply specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains. This specific delivery order for Zepbound reflects the company's role in fulfilling prescription medication needs within the broader pharmaceutical supply chain supporting the Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA2J6?
SPE2DR26FA2J6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FA2J6 worth?
The government has obligated $57,271 on SPE2DR26FA2J6.
Is contract SPE2DR26FA2J6 an order under another contract?
Yes. SPE2DR26FA2J6 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2J6 competed?
The extent of competition for SPE2DR26FA2J6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award